In agreement with the above discussion about nutritional interventions and leptin levels, antioxidant compounds of PD may be a promising natural coadjuvant in the treatment of obesity and cardiovascular disease, acting on adiponectin levels. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.